Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

CompletedOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Cancer
Interventions
BEHAVIORAL

questionnaire administration followed by cognitive interviews

Each cognitive interviewing procedure will include two parts. Participants will first be asked to independently complete a series of PRO-CTCAE symptom items in a Patient Questionnaire. Following completion by the participant of the Patient Questionnaire containing PRO-CTCAE items, the bilingual interviewer will query participants regarding item comprehension, relevance, inclusiveness, cultural appropriateness, and cognitive processes used to generate responses, via a semi-scripted cognitive debriefing interview developed to assure consistency across interviews.

Trial Locations (6)

10065

Memorial Sloan Kettering Cancer Center, New York

60612

Hektoen /Stroger Hospital, Chicago

77030

Md Anderson Cancer Center, Houston

Unknown

St Joseph'S Hospital, Los Angeles

University of Miami, Miami

Ralph Lauren Center for Cancer Care and Prevention, New York

All Listed Sponsors
collaborator

Ralph Lauren Center for Cancer Care and Prevention

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

St. Joseph's Hospital, Los Angeles

UNKNOWN

collaborator

Hektoen Stroger Hospital

UNKNOWN

collaborator

University of Miami

OTHER

collaborator

National Cancer Institute (NCI)

NIH

collaborator

FACITtrans, LLC

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01436240 - Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) | Biotech Hunter | Biotech Hunter